Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
The consensus price target hints at a 37% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Electromed (ELMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The consensus price target hints at a 39.2% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Electromed, Inc. (ELMD) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.16 per share a year ago.
Electromed, Inc. ( ELMD ) Q1 2026 Earnings Call November 12, 2025 5:00 PM EST Company Participants James Cunniff - President, CEO & Director Brad Nagel - CFO, Treasurer & Secretary Conference Call Participants Mike Cavanaugh Kyle Bauser - ROTH Capital Partners, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Presentation Operator Greetings, and welcome to the Electromed First Quarter Fiscal 2026 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
The mean of analysts' price targets for Electromed (ELMD) points to a 52.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Electromed, Inc. (NYSE:ELMD ) Q3 2025 Earnings Conference Call May 13, 2025 5:00 PM ET Company Participants Mike Cavanaugh - IR, ICR Healthcare James Cunniff - President and CEO Bradley Nagel - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Anderson Schock - B. Riley Operator Greetings and welcome to the Electromed Third Quarter Fiscal 2025 Earnings Call.